Axsome Therapeutics (AXSM) Share-based Compensation Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Axsome Therapeutics | 12.28 Bn | 11.98 Bn | 176.48 Mn | 200.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200.12% |
| Dec 31, 2025 | -45.31% |
| Sep 30, 2025 | 1,259.38% |
| Jun 30, 2025 | 2,261.34% |
| Mar 31, 2025 | 45.30% |
| Dec 31, 2024 | 140.36% |
| Sep 30, 2024 | 55.82% |
| Jun 30, 2024 | 57.66% |
| Mar 31, 2024 | -56.84% |
| Dec 31, 2023 | 3.68% |
| Sep 30, 2023 | 78.69% |
| Jun 30, 2023 | 56.57% |
| Mar 31, 2023 | -25.93% |
| Dec 31, 2022 | 136.79% |
| Sep 30, 2022 | -80.04% |
| Jun 30, 2022 | -77.47% |
| Mar 31, 2022 | 82.19% |
| Dec 31, 2021 | 155.52% |
| Sep 30, 2021 | 144.30% |
| Jun 30, 2021 | 125.69% |